Board Performance · 2025
In this section13 topics
- Prevention of Conflicts of Interest3 items
- Prevention of the Use of Inside Information3 items
- Anti-Corruption3 items
- Whistleblowing3 items
- Selection of Directors & Chief Executives10 items
- Selection of Independent Directors3 items
- Evaluation of Board & Subcommittee Performance2 items
- Subcommittees1 item
- Meeting Attendance & Remuneration3 items
- Supervision of Subsidiaries & Associated Companies2 items
- Board Duty Performance — Overview1 item
- Audit Committee Duty Performance1 item
- Executive Committee Duty Performance1 item
Prevention of Conflicts of Interest
Has the Company Acted to Prevent Conflicts of Interest?
Yes
Operations in the Past Year
The Company is committed to acting correctly with the intention of always achieving excellent results. Therefore, employees' performance must prioritize the Company's utmost benefit, in accordance with legal and ethical standards, by avoiding actions that create conflicts of interest that could impact any decision-making.
Number of Conflict-of-Interest Cases
| Metric | Current Year | Previous Year | Two Years Ago |
|---|---|---|---|
| Total number of cases or issues related to conflicts of interest (cases) | 0 | 0 | 0 |
Prevention of the Use of Inside Information
Has the Company Acted to Prevent the Use of Inside Information?
Yes
Operations in the Past Year
The Company has established the Internal Information Usage Policy in the Good Corporate Governance Manual as follows:
1. Directors, executives, employees of the Company, and any third parties performing duties who are aware of or possess the Company’s internal information shall:
1.1 Maintain the Company’s internal information with due care and security to prevent the leakage of such information to external parties.
1.2 Not disclose the Company’s internal information to other persons who are not involved in the operations, in order to prevent the potential use of internal information for their own benefit or the benefit of others, as this may impact the price or value of the Company’s securities, which could affect investment decisions.
2. Directors, executives, employees of the Company, and any third parties performing duties who are aware of or possess the Company’s internal information must not purchase or sell securities related to such internal information, which constitutes taking advantage of other persons trading securities without knowledge of the internal information.
3. Directors, executives, and employees in departments related to internal information, including relevant persons, must comply with the measures prohibiting the trading of securities as prescribed in this policy to prevent the risk of unauthorized use of internal information.
4. Directors, executives, and employees of the Company have a duty to strictly comply with the Charters, Code of Conduct, and Good Corporate Governance Manual, including the use of internal information pursuant to the Securities and Exchange Act B.E. 2535 (and its amendments) (the "Securities and Exchange Act") and the Public Limited Companies Act B.E. 2535 (and its amendments), as well as other relevant regulations.
5. Directors, executives, and employees of the Company who fail to comply with this policy shall be deemed to have committed a disciplinary offense and be subject to punishment. Furthermore, they may be subject to legal penalties if the action constitutes a violation of the law.
Number of Inside-Information Cases
| Metric | Current Year | Previous Year | Two Years Ago |
|---|---|---|---|
| Total number of cases or issues related to the use of inside information to seek benefits (cases) | 0 | 0 | 0 |
Anti-Corruption
Has the Company Acted on Anti-Corruption?
No
Operations in the Past Year
Anti-Corruption Policy
Aikchol Hospital Public Company Limited emphasizes corporate governance within a framework of transparency and accountability, particularly regarding processes that are relevant or susceptible to internal misconduct and all forms of corruption, whether direct or indirect. Accordingly, the Company has established the Anti-Corruption Policy as follows:
Company personnel must not engage in or be involved with any form of corruption or bribery, whether direct or indirect. They are duty-bound to comply with this Anti-Corruption Policy, the Good Corporate Governance Manual, the Code of Conduct, and other relevant rules and regulations.
Company personnel must exercise due care regarding the acceptance or giving of gifts, assets, or any other benefits, including other expenses. The giving or receiving of gifts and hospitality must be for business purposes or customary traditions only, must have an appropriate value, and must not influence decision-making in the performance of duties.
Charitable contributions and sponsorships by the Company must undergo inspection, approval, and review processes, supported by clear documentary evidence in accordance with Company regulations, to ensure that such contributions or sponsorships are not used as a pretext for corruption.
The Company shall establish regular audit processes for procurement and contracting systems and procedures, including assessments of corruption risks and the management of appropriate mitigation methods.
The Company maintains human resource management processes that reflect its commitment to anti-corruption measures. It is the Company's policy not to demote, punish, or adversely affect personnel who refuse to engage in corruption, even if such action results in the loss of business opportunities. The Company shall clearly communicate this policy.
The Internal Audit Department must report self-assessment results to the Audit Committee. Should any non-compliance with the Anti-Corruption Policy be identified, the relevant operational units must be notified to improve control measures.
The Company shall establish procedures for maintaining documents and records to be available for audit, verifying the accuracy and appropriateness of financial reports, and ensuring that no transactions are unrecorded, unexplainable, or false.
The Company shall establish procedures to ensure that internal controls over accounting processes and data retention are audited internally to verify the effectiveness of anti-corruption measures and to ensure that financial records have sufficient evidence for auditing purposes.
The Company shall provide continuous communication and training to its personnel to ensure a true understanding of anti-corruption measures, the Company’s expectations, and the penalties for non-compliance.
The Company shall communicate this Anti-Corruption Policy and guidelines to subsidiaries over which it has control, business partners, stakeholders, and the public through various communication channels for their information and implementation.
Company personnel must not neglect or ignore any action that may violate anti-corruption measures. The Company provides whistleblowing channels and avenues for personnel seeking advice on compliance with these measures.
The Internal Audit Department is authorized to report urgent findings directly to the Chairman of the Executive Committee and the Audit Committee for further reporting to the Board of Directors.
Roles and Responsibilities
Board of Directors
1.1 To determine policies, oversee, and monitor the establishment of an effective system supporting anti-corruption measures, ensuring that the Management recognizes and prioritizes anti-corruption efforts and cultivates it as an organizational culture.
1.2 To comply with anti-corruption measures and ensure that penalties are imposed in the event of non-compliance.
Audit Committee
2.1 To oversee internal controls, the preparation of financial reports, and other processes related to anti-corruption, including supervising compliance with anti-corruption measures.
2.2 To review relevant internal control measures to ensure that anti-corruption measures are adequate and effective.
2.3 To review risk assessments and provide recommendations to the Board of Directors regarding necessary practices to mitigate such risks, which the Management must implement accordingly.
2.4 To regularly report internal audit results concerning the Company’s anti-corruption measures to the Board of Directors, and to provide practical recommendations to both the Board of Directors and the Management.
Executive Committee and Management
3.1 To continuously implement the Anti-Corruption Policy and framework throughout the organization.
3.2 To ensure that corruption risk assessments are conducted in operational processes that may be susceptible to corruption.
3.3 To establish processes that promote and support the Anti-Corruption Policy and communicate them to all employees and relevant parties.
3.4 To review the appropriateness of various systems and measures to ensure they align with business changes, rules, regulations, and legal requirements.
Head of Internal Audit
4.1 To audit and review operations to ensure they are conducted correctly and in accordance with policies, guidelines, authority, operating procedures, laws, and internal audit requirements; this is to ensure that the control systems are appropriate and sufficient for potential corruption risks, and to report findings to the Audit Committee.
Guidelines
Directors, executives, and employees of Aikchol Hospital Public Company Limited must comply with the Anti-Corruption Policy and the Good Corporate Governance Policy, strictly avoiding any involvement in corruption, whether direct or indirect.
The Company recognizes the importance of disseminating information, providing education, and fostering understanding among other persons performing duties related to the Company and its stakeholders.
The Company is committed to developing its personnel to be good citizens of society and the nation.
Directors, executives, and employees must comply with the Anti-Corruption Policy, Good Corporate Governance Manual, Corruption Risk Management Manual, Anti-Corruption Manual, Code of Conduct, and any other guidelines established or to be established by the Company, avoiding any direct or indirect involvement in corruption.
Employees should not neglect or ignore any suspicious acts or activities that may constitute corruption. They must notify their supervisors, responsible persons, or report through designated channels and cooperate in fact-finding investigations as prescribed in Company regulations.
The Company shall provide fairness and protection to employees who refuse to engage in or report corruption related to Company activities. They will not be demoted, punished, or adversely affected. The Company will strictly implement whistleblower protection measures in accordance with human resources policies and/or whistleblowing measures.
Any person who commits corruption is deemed to have violated the Code of Conduct and will be subject to disciplinary action according to Company regulations, and may face legal penalties if the act is unlawful.
The Company communicates the Anti-Corruption Policy, measures, and whistleblowing/feedback channels internally through various methods, such as director and employee orientations, the intranet system, and newsletters, to ensure effective implementation.
The Company communicates the Anti-Corruption Policy, measures, and whistleblowing/feedback channels to the public and stakeholders through various methods, such as the Company’s website and annual reports.
The Company provides anti-corruption risk management by conducting risk assessments, prioritizing risks, establishing appropriate measures, and monitoring the progress of implemented measures.
The Company manages human resources to reflect its commitment to anti-corruption, covering recruitment, training, performance evaluation, compensation, promotion, and organizational structuring with appropriate segregation of duties for checks and balances, ensuring sufficient resources and skilled personnel are available to implement this policy.
The Company establishes clear, rigorous, effective, transparent, and auditable regulations regarding approval authority for business transactions.
The Company provides internal control systems covering finance, accounting, data recording, and other internal processes related to anti-corruption, and communicates internal control results to responsible personnel.
The Company provides internal audits covering key activities, such as procurement and finance/accounting, to ensure that internal control systems achieve their goals and that operations comply with procedures and regulations, while providing recommendations for improvement.
This Anti-Corruption Policy covers all activities related to the Company’s operations.
To ensure clarity in high-risk areas, directors, executives, and employees at all levels must exercise due care in the following matters:
16.1 Gifts, Souvenirs, Hospitality, and Expenses: Giving or receiving gifts and hospitality must be within reasonable bounds of custom and tradition, must not have excessive value, and must not serve as an inducement to act or omit action that may lead to corruption, in accordance with the Code of Conduct and Good Corporate Governance Manual.
16.2 Charitable Contributions or Sponsorships: The Company has a policy to control and exercise caution regarding contributions or sponsorships to ensure they do not become channels for corruption. This includes clear, rigorous, and effective procedures for verification and tracking. Contributions or sponsorships must be transparent, lawful, and not used as a pretext for bribery.
16.3 Business Relationships and Procurement: Bribery is prohibited in all business dealings with partners, contractors, government agencies, or entities doing business with the Company. All processes must be transparent, honest, and in compliance with relevant laws.
16.4 Political Neutrality and Support: The Company maintains a policy of political neutrality and does not provide direct or indirect support to any political party. This includes the use of Company resources for activities that would cause the Company to lose its political neutrality and/or suffer damage from such involvement.
Number of Corruption Cases
| Metric | Current Year | Previous Year | Two Years Ago |
|---|---|---|---|
| Total number of cases or issues related to corruption (cases) | 0 | 0 | 0 |
Whistleblowing
Has the Company Implemented Whistleblowing Procedures?
No
Operations in the Past Year
The company has established a Whistleblowing Policy to monitor and prevent corruption, violations of policies, and corporate governance practices, by accepting reports or complaints through the following channels:
Channels for external parties
- Electronic mail / E-mail: whistleblower@aikchol.com
- By mail: Chairman of the Board / Chairman of the Audit Committee
Aikchol Hospital, No. 68/3, Moo 2, Phraya Satcha Road, Ban Suan Subdistrict, Mueang District, Chonburi Province 20000
Aikchol Hospital Ang Sila, No. 31/2, Moo 3, Ang Sila Road, Samet Subdistrict, Mueang District, Chonburi Province 20000
Channels for internal personnel
Complaints can be submitted either anonymously or with disclosure of identity via the Intranet system, internal email (webmail): whistleblower@aikchol.local
Additionally, employees/personnel may inquire or submit complaints if they observe any actions suspected of violating or not complying with the code of conduct, to their trusted supervisor at any level.
The company discloses its policy for protecting and ensuring fairness for employees who report information or provide tips regarding corruption or non-compliance with laws, regulations, rules, and the company's code of conduct. This policy details the eligible complainants, recipients of complaints, complaint methods, fact-finding procedures, and protective measures for whistleblowers, all available on the company's Investor Relations Website.
Number of Whistleblowing Cases
| Metric | Current Year | Previous Year | Two Years Ago |
|---|---|---|---|
| Total number of cases or issues received through whistleblowing channels (cases) | 0 | 0 | 0 |
Selection of Directors & Chief Executives
Selection, Development & Evaluation — Introduction
In the appointment of directors, the Nomination Committee, comprising 2 independent directors out of a total of 3 Nomination Committee members, is responsible for considering, selecting, and screening individuals with suitable qualifications in accordance with the company's regulations, and for nominating qualified individuals to ensure professional and diverse directors, taking into account the structure, size, and composition of the Board of Directors. The Committee submits its recommendations to the Board of Directors to seek approval from the directors and subsequently presents the names of these directors to the shareholders' meeting for election in accordance with the established criteria.
The Nomination Committee has considered the nature of the business operations and future plans, and has therefore established the qualifications for directors. Directors must possess knowledge in medical matters and the hospital business, and have experience in these areas. Furthermore, the Nomination Committee has provided an opportunity for shareholders to participate in nominating qualified directors. In 2025, shareholders were given the opportunity to submit nominations from October 1, 2024, to December 31, 2024. It was found that no shareholders submitted nominations. Nevertheless, the Nomination Committee proposed to the Board of Directors' meeting the appointment of the Chief Executive Officer (CEO) to serve as a director.
Selection — Introduction
In accordance with good corporate governance principles for listed companies, it is recommended that listed companies have a process for nominating individuals for appointment as directors and top executives through a nominating committee. The Company has adopted these guidelines and adapted them to its business, taking into account the necessities for the Company's business management.
Board Skill Matrix of the Company are as follows:
Medical | Accounting | Finance | Business Administration | Law | IT | ||
| Wanich | / | |||||
| Banchuen | / | |||||
| Wanich | / | |||||
| Wanich | / | |||||
| Photanan | / | |||||
| Rueangsuwan | / | |||||
| Yuktanand | / | |||||
| Pongsathian | / | |||||
| Sirichaisakul | / |
The Company has established recruitment criteria in its Corporate Governance Handbook as follows:
Recruitment and Appointment of Company Directors
Recruitment of Company Directors
The Nomination and Remuneration Committee is tasked with considering the qualifications and selecting individuals to serve as company directors, and then submitting these names to the Board of Directors for approval. In the event of appointing a new director to fill a vacancy before the end of the term, the appointment must receive no less than three-fourths of the votes from the remaining directors. In the case of appointing new directors, the Nomination and Remuneration Committee will propose names to the Board of Directors for consideration and submission to the shareholders' meeting for approval of the appointment.
For the election of directors, shareholders shall cast their votes for each director individually, using all votes they possess to elect each nominated individual one by one.
Qualifications of Directors
1. Company directors must be individuals with knowledge and ability, integrity, business ethics, and sufficient time to dedicate their knowledge and abilities to perform duties for the Company.
2. Company directors must not hold positions in more than 5 listed companies.
3. Directors are prohibited from engaging in business, becoming partners, or serving as directors in other legal entities of the same nature that compete with the Company's business, unless they inform the shareholders' meeting before the appointment resolution. Directors must also promptly inform the Company if they have any interest in contracts made by the Company, or if their share or debenture holdings in the Company or its subsidiaries increase or decrease.
4. Possess qualifications and not exhibit prohibited characteristics under the Public Limited Company Act and the Securities and Exchange Act.
5. Independent directors must meet the qualifications stipulated by the Stock Exchange of Thailand and the Securities and Exchange Commission (SEC).
6. Company directors must be selected by the Company's Nomination and Remuneration Committee.
Directors & Chief Executives — Introduction
Recruitment of Senior Executives
For the recruitment of individuals to hold senior executive positions, from the level of Director, Deputy Director, to Assistant Director, the Executive Committee will conduct an initial review to screen and select individuals who possess full qualifications, suitability, knowledge, abilities, skills, and experience beneficial to the company's operations, and who have a thorough understanding of the company's business. They must also be capable of managing operations to achieve the objectives and goals set by the Board of Directors. These candidates will then be proposed to the Nomination and Remuneration Committee for consideration, which will subsequently present them to the Board of Directors for final approval.
Selection Process — Introduction
Senior executive recruitment primarily considers the company's business. The recruitment process utilizes referrals from known individuals and headhunting services.
Are Directors Selected Through the Nomination Committee?
Yes
Are Chief Executives Selected Through the Nomination Committee?
Yes
Directors from Major Shareholders — Introduction
Directors originating from major shareholders are primarily those whose appointments stem from the founding family's relationships. These directors do not assume executive positions; however, some of them still retain management authority.
Number of Directors from Major Shareholders
3
Rights of Minority Shareholders on Director Appointment
The Company annually provides shareholders with the opportunity to nominate individuals for directorships. For the year 2025, shareholders were invited to submit nominations from October 1, 2024, to December 31, 2024.
Method of Director Appointment
| Method |
|---|
| Method whereby each director requires approval votes more than half of the votes of attending shareholders with voting rights |
Selection of Independent Directors
Introduction
The Company stipulates the appointment of independent directors to provide independent opinions on the financial statements and the Company's business operations.
Criteria for Selecting Independent Directors
Independent directors must meet the qualifications prescribed by the Stock Exchange of Thailand and the Securities and Exchange Commission, namely:
1. Holds no more than 1% of the total voting shares in the company, its affiliates, associated companies, or any person who may have a conflict of interest (including related persons under Section 258 of the Securities and Exchange Act).
2. Is not, or has never been, an executive director, employee, staff member, salaried advisor, or a person with control over the company, its parent company, subsidiaries, associated companies, same-level subsidiaries, major shareholders, or persons with control over the company, unless such characteristics have ceased for at least two years prior to the date of appointment.
3. Is not a person related by blood or legal registration as a parent, spouse, sibling, or child, including the spouse of a child, of an executive, major shareholder, controlling person, or a person nominated to be an executive or controlling person of the company or its subsidiaries.
4. Has no, or has never had, a business relationship with the company, its parent company, subsidiaries, associated companies, or any entity that may have a conflict of interest, in a manner that could impede the exercise of independent judgment. This includes not being, or having never been, a major shareholder, a non-independent director, or an executive of any entity having a business relationship with the company or any entity that may have a conflict of interest, unless such characteristics have ceased for at least two years prior to the date of appointment.
5. Is not, or has never been, an auditor of the company, its parent company, subsidiaries, associated companies, or any entity that may have a conflict of interest, and is not a major shareholder, a non-independent director, an executive, or a managing partner of an audit firm where the company's auditor or an entity that may have a conflict of interest is affiliated, unless such characteristics have ceased for at least two years prior to the date of appointment.
6. Is not, or has never been, a professional service provider, including legal or financial advisors, who receives service fees exceeding two million baht per year from the company, its parent company, subsidiaries, associated companies, or any entity that may have a conflict of interest. In the case where the professional service provider is a juristic person, this includes being a major shareholder, a non-independent director, an executive, or a managing partner of that professional service provider, unless such characteristics have ceased for at least two years prior to the date of appointment.
7. Is not a director appointed as a representative of the company's directors, major shareholders, or shareholders related to the company's major shareholders.
8. Possesses no other characteristics that would prevent the independent expression of opinions regarding the company's operations.
9. Independent directors must serve for no more than 9 years.
Did Any Independent Director Have a Business or Professional Relationship?
No
Evaluation of Board & Subcommittee Performance
Criteria for Evaluating Board Performance
The company's directors are required to evaluate the performance of the entire board annually, by individually assessing their own performance of duties and compiling the evaluation results, in order to review performance, problems, and obstacles for the continuous improvement of the board's operational efficiency.
Evaluation of Board Performance in the Past Year
- Self-assessment results of the Board as a whole accounted for 55.56%
(Calculated from 5 returned assessment forms out of a total of 8 directors)
- Self-assessment results of individual directors accounted for 51.70%
(Calculated from 5 returned assessment forms out of a total of 8 directors)
- Self-assessment results of the Audit Committee accounted for 25.00%
(Calculated from 1 returned assessment form out of a total of 4 directors)
- Self-assessment results of the Nomination and Remuneration Committee accounted for 33.33%
(Calculated from 1 returned assessment form out of a total of 3 directors)
- Cross-individual assessment (assessing other directors): None
Subcommittees
Subcommittees
| Results of the Subcommittee's Duty Performance |
|---|
Performance of duties by the Nomination and Remuneration Committee in 2025. Consideration of Recruitment
Mr. Koodun Sukumanont resigned from the Board of Directors on September 26, 2025.
Consideration of Remuneration
|
Meeting Attendance & Remuneration
Meeting Attendance — Remark
Types of Remuneration of the Board of Directors
In accordance with Section 90 of the Public Limited Company Act B.E. 2535 (1992) and Article 20 of the Company's Articles of Association, it is stipulated that: "Directors of the Company are entitled to remuneration for their performance of duties, which includes salaries, gratuities, bonuses, or other benefits as the Shareholders' Meeting may determine a fixed amount or establish as a principle. This may be determined on an ad hoc basis or may remain in effect until changed. Furthermore, they shall receive allowances, meeting fees, or various welfare benefits as determined by the Shareholders' Meeting."
Director remuneration should be commensurate with the duties and responsibilities of the directors and subject to annual review. For the 2024 director remuneration, the Nomination and Remuneration Committee has considered it according to the criteria and procedures for proposing remuneration and thus proposes the director remuneration. This proposal is based on the industry group and the company's performance, to seek approval from shareholders for appropriate remuneration for the Board of Directors and sub-committees under current circumstances, at the Annual General Meeting of Shareholders for 2024.
Remuneration or Benefits Payable to the Board
| Metric | Amount (Baht) |
|---|---|
| Remunerations or benefits pending payment to the board of directors over the past year (baht) | 0 |
Supervision of Subsidiaries & Associated Companies
Does the Company Have Subsidiaries or Associated Companies?
No
Is There a Mechanism for Overseeing Subsidiaries and Associated Companies?
No
Board Duty Performance — Overview
Board Duty Performance — Overall Description
In the past year 2025, the Board of Directors performed its duties in Board of Directors meetings to consider the company's operating results, consider the financial statements, and organize the Annual General Meeting of Shareholders in accordance with the principles of the Act and relevant laws. The Board of Directors held a total of 7 meetings, in accordance with the pre-scheduled meeting plan, which was approved at the November 2024 meeting. Of these, one meeting was a special agenda outside the pre-scheduled plan.
As of December 31, 2025, the Board of Directors comprised a total of 9 members. At the Annual General Meeting of Shareholders for 2025, held on April 18, 2025, the Chief Executive Officer (CEO) was appointed as a company director / authorized signatory director (executive director). On September 26, 2025, Mr. Koodan Sukumanont, Independent Director / Audit Committee Member, resigned due to extensive commitments. Mr. Kiattiporn Sirichaisakul was appointed as his replacement and was resolved to be appointed as an Independent Director / Audit Committee Member on November 13, 2025. His term of office will be for the remaining period of Mr. Koodan Sukumanont's term.
Audit Committee Duty Performance
Results of the Audit Committee's Duty Performance in the Past Year
Show in Attached document 6
Executive Committee Duty Performance
Results of the Executive Committee's Duty Performance in the Past Year
Report on the performance summary of the Executive Committee.
-
Report the company's operational performance to the Board of Directors on a quarterly basis.
-
Present goals, business strategies, and annual work plans to the Board of Directors, as well as be responsible for managing the company's operations in accordance with established policies, directions, and objectives.
-
Oversee the preparation of financial reports for auditors to examine or review, and attend meetings with auditors to consider such financial statements before the auditors present them to the Audit Committee.
-
Drive the successful completion of the HA Reaccreditation assessment.
-
Consider and propose the annual budget and investments to the Board of Directors for approval.
-
Supervise, promote, and support executives and employees in understanding the company's various policies and operational procedures.

